Related Experiment Video
Updated: Dec 20, 2025

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
Embolic ST-elevation Myocardial Infarction from Candida Endocarditis
Amre Ghazzal1, Gauravpal S Gill1, Sohab Radwan1
1Internal Medicine, MedStar Washington Hospital Center, Washington, USA.
Insights
This rare case highlights Candida endocarditis in intravenous drug users, leading to ST-elevation myocardial infarction. Management of this complex condition involves antifungal therapy and careful consideration of anticoagulation and interventions.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Case Study
Background:
- Infective endocarditis typically affects right-sided heart valves, with left-sided native valve involvement being uncommon, especially in intravenous drug users.
- Candida species are a rare cause of infective endocarditis, further increasing the rarity of this case.
Observation:
- The patient presented with ST-elevation myocardial infarction, a serious complication of infective endocarditis.
- Embolic myocardial infarction, particularly from septic sources like Candida endocarditis, is associated with poorer outcomes.
Findings:
- Management of Candida endocarditis with myocardial infarction requires antifungal therapy.
- The use of antithrombotic therapy and anticoagulation is controversial due to significant risks of neurologic complications.
- Percutaneous coronary interventions present challenges, with aspiration embolectomy noted as a potentially safer option than balloon angioplasty and stenting.
Implications:
- This case underscores the complexity in managing rare instances of Candida endocarditis causing ST-elevation myocardial infarction.
- Optimal treatment strategies require a multidisciplinary approach, balancing antifungal therapy with cautious consideration of antithrombotic and interventional options.
- Surgical intervention remains an option for refractory cases or when valve replacement is indicated.
Abstract:
Infective endocarditis in intravenous drug users is uncommon in left-sided native valves. Adding to the rarity, in this case, is endocarditis from Candida species complicated by ST-elevation myocardial infarction. Embolic myocardial infarction has worse outcomes as compared to other etiologies, and the management of septic embolic myocardial infarction is rather challenging. The management of embolic myocardial infarction from Candida endocarditis vegetation includes antifungal therapy. The use of anti-thrombotic therapy and anticoagulation carries a significant risk of fatal neurologic complications and has been controversial, with limited observational data available. Among percutaneous coronary interventions, balloon angioplasty and stenting have been associated with multiple complications while aspiration embolectomy appears to be a safer option. Surgical management is considered if medical and interventional therapies fail or if there is an indication for valve replacement.
More Related Videos
08:31Candida albicans Biofilm Development on Medically-relevant Foreign Bodies in a Mouse Subcutaneous Model Followed by Bioluminescence Imaging
Published on: January 27, 2015
08:48Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction